Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.72% | -33.18% | -41.60% |
15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
14/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.60% | 14Cr | |
+12.15% | 23TCr | |
+14.90% | 20TCr | |
+18.22% | 14TCr | |
+29.15% | 11TCr | |
+0.53% | 6.41TCr | |
+16.92% | 5.37TCr | |
+6.33% | 5.17TCr | |
+10.93% | 4.52TCr | |
+5.87% | 3.74TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M